MedTech Strategist

When it comes to strategizing and networking, your time is money. Why throw yourself in the ocean when you could be in a pond? At MedTech Strategist's Innovation Summit, you won't drown trying to get the attention you deserve when you have goals to accomplish and numbers to make. This conference is the #MedTech industry's only intimate networking and investing conference that puts the power in your hand by giving you space to breathe and learn with ease. Give yourself the competitive advantage. Climb the Summit to Innovation: https://bit.ly/3ygP9vr

Join Edwards Lifesciences’ Perry Bridger, Lightstone Ventures’ Mike Carusi, and Medical Device Innovation Consortium (MDIC)’s Harry Kotlarz at Innovation Summit San Diego 2024 in the panel session “Cracking the Black Hole of Private Payer Reimbursement.” 🎙️ Stephen Levin, Editor-in-Chief of Market Pathways, will be moderating the discussion featuring these esteemed panelists on Wednesday, November 20 from 10:35-11:15AM: Perry Bridger is Senior Advisor to Edwards Lifesciences where he provides strategic commercialization, market access, and public affairs guidance to the company’s executive leadership team. He established the company’s integrated global market access functions in 2011. Mike Carusi is a General Partner and Team Leader of Lightstone Ventures (LSV) and focuses on investments in the biopharmaceutical and medical device sectors. He is based in the firm’s Menlo Park, CA office, where he also serves as a General Partner at Advanced Technology Ventures (ATV). His representative investments include Allay Therapeutics, Altura Medical (acquired by Lombard), Ardian (acquired by Medtronic), Cala Health, EndoGastric Solutions, Gynesonics, MediSix Therapeutics, MicroVention (acquired by Terumo), Nuvaira, Plexxikon (acquired by Daiichi Sankyo), PowerVision (acquired by Alcon), Second Genome, Shoulder Innovations, Tallac Therapeutics, and Willow. Harry Kotlarz brings more than two decades of leading health economics and market access functions to his role. His blend of industry experience, multiple stakeholder engagement, and evidence-based solutions has contributed to coverage and access for innovative technologies helping more patients.   He has been responsible for the evidence required for value-based healthcare, reimbursement, and health policy-related issues including quality, new payment models, comparative effectiveness, and cost-effectiveness outcomes. Welcome to #InnovationSanDiego, Perry, Mike, and Harry! Climb the Summit to #MedTech Innovation November 19-21, 2024 at The US Grant Hotel in San Diego, California to easily connect and network with the industry's top key players without the typical conference hurdles. Register today: https://bit.ly/4gBjKW6

Over the past decade, the field of medtech has undergone significant advancements, particularly in clinical trials. One of the most transformative innovations has been the adoption of sensor technologies. Sensors, both wearable and implantable, have revolutionized patient monitoring, data collection, and overall #healthcare delivery. This article explores the pivotal role of sensors in medtech clinical studies, highlighting their impact, potential, and the growing market demand for these technologies. Sensor technologies play a transformative role in #medtech, particularly in clinical trials. Wearable and implantable sensors are revolutionizing patient monitoring, data collection, and personalized healthcare, offering continuous, real-time insights and improved patient outcomes. By Derek Thomas, Global Client Executive, MedTech, Medidata Solutions: https://bit.ly/3UBaZSJ

MedTech Strategist is honored to welcome Solenic Medical Inc. alongside CEO James Lancaster as a Presenting Company at Innovation Summit San Diego 2024. Presenting in the Orthopedics-Spine and Infection Treatment Therapeutic Categories, Solenic Medical, Inc. (Addison, Texas, USA) is clinical stage company pioneering a non-invasive solution for infected implants, like prosthetic knees and hips, utilizing alternating magnetic fields (AMF). This technology, designated a U.S. FDA Breakthrough Device, targets infections complicated by biofilms on implant surfaces. In-vitro and large animal studies demonstrated a significant bacteria reduction within safe temperature ranges. The solution targets safe and effective treatment for implant infections. Welcome to #InnovationSanDiego, James and Solenic Medical Inc.! 🤝 Climb the Summit to San Diego November 19-21, 2024: https://bit.ly/4gBjKW6 #orthopedics #medicaldevices #medtech #invitro #implants #implantinfections #infectiontreatment 

We are thrilled to welcome Latham & Watkins as a Gold Sponsor of Innovation Summit San Diego 2024. Thank you for your generous support! Latham & Watkins delivers innovative solutions to complex legal and business challenges around the world. From a global platform, their lawyers advise clients on market-shaping transactions, high-stakes litigation and trials, and sophisticated #regulatory matters. Latham is one of the world’s largest providers of pro bono services, steadfastly supports initiatives designed to advance diversity within the firm and the legal profession, and is committed to exploring and promoting environmental sustainability. Welcome to #InnovationSanDiego, Latham & Watkins! View the official agenda and register to attend today: https://bit.ly/3ygP9vr

MedTech Strategist is honored to welcome Eyedaptic alongside President & CEO Jay Cormier as a Presenting Company at Innovation Summit San Diego 2024. Presenting in the Ophthalmology, Augmented Reality, Artificial Intelligence, and Digital Health Therapeutic Categories, Eyedaptic (Laguna Hills, CA, USA) is pioneering the use of Augmented Reality (AR), powered by Artificial Intelligence (AI), to address the large unmet eye care need of Retinal Diseases, such as Macular Degeneration, afflicting over 200 million people worldwide. Effectiveness has been demonstrated, leading to strong user adoption and traction. These ultralight smart glasses adapt not only to the user’s vision but also their habits and environment, thereby empowering users to maintain their independence and quality of life across the widest range of tasks. Welcome to #InnovationSanDiego, Jay and Eyedaptic! 🤝 Climb the Summit to San Diego November 19-21, 2024: https://bit.ly/4gBjKW6 #medicaldevices #medtech #medtechinnovation #augmentedreality #digitalhealth #retinaldiseases #artificialintelligence #ophthalmology #AI

This procedure, when deployed, can enhance CPR’s effectiveness by 200%, offering increased circulatory support in critical cases. And that procedure is called REBOA. Asha Parekh co-founded Front Line Medical Technologies Inc. to create and commercialize COBRA-OS, a device that simplifies the REBOA procedure for emergency settings. Front Line’s initial focus was #trauma cases, including civilian and military injuries with noncompressible torso hemorrhage, where survival rates are low. The device is also used prophylactically for postpartum hemorrhage and high-risk pregnancies. The COBRA-OS features a uniquely small (4 French) delivery sheath, minimizing vessel obstruction and reducing access site complications. Its conical balloon shape allows for parallel inflation, minimizing aorta damage and enabling partial REBOA. The COBRA-OS kit is sold in boxes of five, with no contracts or subscriptions, and is competitively priced. It comes with standard #reimbursement in the US, and a National Stock Number facilitates military purchasing. Parekh envisions COBRA-OS becoming a standard tool in every ambulance and emergency service setting. The company holds two patents and has more pending, securing COBRA-OS’s innovative design and packaging. Read more about the Ontario start-up offering an updated aortic balloon occlusion system to boost safety and ease of use: https://bit.ly/40kCq6N #medtech #medicaldevices #startups #medtechinnovation

Join IQVIA MedTech's Kelley Kennedy, MCRA, an IQVIA business's Tim Marjenin, and MCRA, an IQVIA business's Kenneth Rayl at Innovation Summit San Diego 2024 in the panel session "Clinical Trials for Today’s FDA: Diversity, Digital, and Novel Designs." 🎙️ David Filmore, Executive Editor of Market Pathways, will be moderating the discussion featuring these esteemed panelists on Tuesday, November 19 from 2:40-3:10PM: Kelley Kennedy provides strategic direction and therapeutic expertise to guide medical device companies through the clinical development landscape. Kelley has 20+ years of experience in global #clinicalresearch, including leadership roles at Medtronic and clinical positions at Mt. Sinai and NYU Medical Center. Tim Marjenin has over 20 years of experience and expertise in the regulation of neurological #devices. He specializes in invasive and non-invasive neuromodulation for various conditions, including movement disorders, epilepsy, and psychiatric conditions. Tim holds a bachelor’s degree in biomedical engineering from Case Western Reserve University. Kenneth Rayl has over 19 years of research experience, focusing on clinical trials for digital therapeutics over the past 7 years. At MCRA, he oversees research operations for clinical trials and collaborates with #regulatory teams. He holds a bachelor’s degree in biological sciences from the University of Pittsburgh and an MBA in Healthcare Management from Carlow University. Welcome to #InnovationSanDiego, Kelley, Tim, and Kenneth! Climb the Summit to #MedTech Innovation November 19-21, 2024 at The US Grant Hotel in San Diego, California to easily connect and network with the industry's top key players without the typical conference hurdles. Register today: https://bit.ly/4gBjKW6

MedTech Strategist is honored to welcome SynerFuse alongside CEO & Co-founder Justin Zenanko as a Presenting Company at Innovation Summit San Diego 2024. Presenting in the Neuromodulation-Neurostimulation and Spinal Fusion Rehabilitation Therapeutic Categories, the patented SynerFuse™ (Eden Prairie, Minnesota, USA) procedure, Electric Transforaminal Lumbar Interbody Fusion (e-TLIF™), combines fusion with direct nerve stimulation to address chronic low back and leg pain that is unaddressed in traditional spinal fusion surgery. The aims of SynerFuse is to decrease number of back fusions/surgeries related to pain and address chronic pain at the point of surgery. Welcome to #InnovationSanDiego, Justin and SynerFuse! 🤝 Climb the Summit to San Diego November 19-21, 2024: https://bit.ly/4gBjKW6 #medtech #medicaldevices #medtechinnovation #chronicpain #spinalfusion #spinalfusionsurgery #nervestimulation

We are thrilled to welcome Medtronic as a Platinum Sponsor of Innovation Summit San Diego 2024. Thank you for your generous support! Headquartered in Dublin, Ireland, Medtronic is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together. Welcome to #InnovationSanDiego, Medtronic! View the official agenda and register to attend today: https://bit.ly/3ygP9vr #Medtronic #medicaldevices #medtech #medicaltechnology